Virax Biolabs Group Ltd
General ticker "VRAX" information:
- Sector: Health Care
- Industry: Health Care Providers & Services
- Capitalization: $4.1M
Virax Biolabs Group Ltd follows the US Stock Market performance with the rate: 27.2%.
Estimated limits based on current volatility of 9.2%: low 1.65$, high 1.99$
Short-term VRAX quotes
Long-term VRAX plot
Financial data
| YTD | 2023-03-31 | 2024-03-31 |
|---|---|---|
| Operating Revenue | $0.01MM | $0.16MM |
| Operating Expenses | $5.74MM | $6.65MM |
| Operating Income | $-5.73MM | $-6.50MM |
| Non-Operating Income | $0.27MM | $-0.24MM |
| Interest Expense | $0.02MM | $0.03MM |
| R&D Expense | $0.40MM | $1.56MM |
| Income(Loss) | $-5.46MM | $-6.74MM |
| Taxes | $-0.00MM | $-0.01MM |
| Profit(Loss) | $-5.46MM | $-6.73MM |
| Stockholders Equity | $9.13MM | $5.37MM |
| Inventory | $0.02MM | $0.06MM |
| Assets | $9.81MM | $5.48MM |
| Operating Cash Flow | $-4.18MM | $-6.25MM |
| Capital expenditure | $0.18MM | $1.16MM |
| Investing Cash Flow | $-0.18MM | $-1.16MM |
| Financing Cash Flow | $13.69MM | $1.65MM |
| Earnings Per Share* | $-5.13 | $-3.36 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.